Articles tagged with Induced Pluripotent Stem Cells
Scientists at ASHBi have successfully generated a 3D model that recapitulates the early stages of human body plan development, including somite formation and axial skeleton development. The study revealed the importance of retinoids in this process and demonstrated its potential for understanding congenital spine disease.
Researchers at Osaka University have successfully induced precursors of eggs and sperm in white rhinoceros cells, paving the way to possibly rebuilding northern white rhino populations. This breakthrough uses advanced assisted reproductive technologies to address a key challenge in conservation efforts.
Scientists have successfully created primordial germ cell-like cells (PGCLSs) from induced pluripotent stem cells of the northern white rhino Nabire, paving the way to produce artificial gametes. This breakthrough aims to prevent the extinction of the northern white rhinoceros and increase genetic diversity.
Researchers at the Max Delbrück Center have successfully generated primordial germ cells from stem cells, a world's first for a large mammalian species. This milestone aims to save the northern white rhino subspecies from extinction through lab-grown egg and sperm cells.
Researchers generated induced pluripotent stem cells and cerebral organoids from the last male Malaysian Sumatran rhino, enabling study of brain development and potentially aiding in breeding program. The technology holds promise for fighting extinction of critically endangered species.
Researchers created iPSCs from Okinawa rail, Japanese ptarmigan, Blakiston's fish owl, and Japanese golden eagle for conservation. The cells can differentiate into various cell types, providing a valuable resource for evaluating disease risks and pollution.
A new stem cell study provides insight into how neurons from individuals with post-traumatic stress disorder (PTSD) respond to stress hormones. The research found that these cells are hypersensitive to the stress hormone hydrocortisone, which could help explain why some people develop PTSD after trauma exposure.
Researchers discover that oxytocin stimulates stem cells to migrate and develop into cardiomyocytes in zebrafish and human cell cultures. This could lead to the regeneration of damaged hearts after a heart attack. The study found that oxytocin also activates EpiPCs, which can replenish lost cardiomyocytes.
Researchers at UNSW Sydney have made significant discoveries about embryonic blood stem cell creation that could one day eliminate the need for blood stem cell donors. Two studies have emerged from UNSW researchers in this area that shine new light on how precursors to blood stem cells occur in animals and humans, and how they may be i...
Researchers have developed a mouse embryo model using only embryonic stem cells, achieving a high level of developmental stages including beating hearts and brain formation. This advancement opens up new avenues for understanding human pregnancy loss and developing organs in culture.
Researchers have created a stem cell-based model of the human liver, allowing for the study of how Ebola virus infects liver cells. The infected cultures showed that viral infection directly disrupts liver function, while immune cells can transfer the virus to other cells.
Researchers developed a method to produce generic CAR T cells from induced pluripotent stem cells (iPS cells), which could be produced at scale for multiple patients. The new cells showed enhanced anti-tumor activity and comparable efficacy to current clinical-grade cells.
Scientists at Cincinnati Children's develop a 'plug-and-play' method to consistently produce large numbers of lab-grown small intestines, colons, and stomachs. The new process overcomes the bottleneck of inconsistent organoid production, enabling faster and more accessible research.
Researchers have created stem cell models that mimic the genetic disorder, revealing the role of WASP protein in regulating RNA splicing and finding potential therapeutic targets. These findings could lead to new treatments for Wiskott-Aldrich syndrome, a devastating immune deficiency disorder.
Izpisua Belmonte's work on cellular rejuvenation programming has the promise to improve aging and age-associated diseases, with potential therapies for new treatments. He was recognized for his innovations leading to discoveries that can reset a cell's aging clock, allowing organs to regenerate.
Two preclinical studies have identified potential new therapies for patients with Allan-Herndon-Dudley syndrome (AHDS), a brain development disorder that causes severe intellectual disability and movement problems. A gene therapy approach has shown promise in improving cognitive and motor functions, while repurposing a common drug may ...
Scientists at Osaka University created 3D human stem cell-derived lacrimal gland organoids that mimic the human tear duct. The organoids exhibited organization and branching patterns characteristic of the human lacrimal gland, demonstrating potential as a platform for regenerative therapies for dry eye syndrome.
Scientists at Johns Hopkins Medicine have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice. The self-renewing stem cells were created by reprogramming laboratory-grown human skin cells, which then differentiated into specific cell types using a nutrient-rich broth.
A team of researchers from Osaka University and Kyoto University developed a stem cell-based biomaterial, hiPS-Cart, to treat IVD degeneration and prevent further deterioration. The biomaterial was able to survive and maintain its functionality in lab rats with NP removal, reversing IVF and vertebral bone degeneration.
Researchers discovered that Viagra and a common over-the-counter drug TUDCA restored mitochondrial processes, which drive heart failure in HLHS patients. This could lead to new therapies for treating heart failure without relying on heart transplants.
Researchers have successfully generated large numbers of virus-resistant immune cells from monkeys using CRISPR/Cas9 gene editing. This breakthrough could lead to the development of a new treatment for HIV/AIDS by providing an alternative to current therapies that require lifelong medication and can cause side effects.
Researchers successfully differentiated human induced pluripotent stem cells into specific mesoderm subset for use as a novel therapy to rescue ischemic tissues and repair blood vessels. The results demonstrate significant improvement in visual acuity and electroretinograms with restoration of vascular perfusion in animal models.
A new cloud-based data resource has been developed to help identify new subtypes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder. The tool, part of the Answer ALS collaborative effort, uses biological and clinical data from over 1,000 patients to better understand the disease.
A recent study by Gladstone Institutes researchers found that mouse stem cells can spontaneously transition from heart cell precursors to brain cell precursors when a specific gene is removed. This discovery upends current understanding of how stem cells differentiate into adult cells and maintain their identity. The study's findings h...
Researchers developed a novel multi-organoid system to simulate the human liver-islet axis, enabling 3D co-culture of hiPSC-derived organoids for up to 30 days. The system exhibited cooperative interaction between liver and islet organoids, reflecting the dynamic interplay among organs in type 2 diabetes.
Researchers at RIKEN have developed a new retinal transplant technique by engineering human-derived retina sheets to lose bipolar cells, allowing better connections to host retinas and improved responses to light. The technique has shown substantial functional improvement in animal studies and is now poised for human clinical trials.
Researchers have discovered molecules that could be candidates for contraceptives or fertility enhancers using human blastoid models. These models also show promise in improving the self-organization of stem cells during IVF procedures.
Researchers at Mount Sinai have developed a diverse library of well-characterized human induced pluripotent stem cell lines from clinically healthy individuals, offering valuable resources for studying normal human biology, evaluating drug responses, and disease modeling.
Stem cell researchers have developed a new method to identify and develop personalized therapies for Cystic Fibrosis patients with rare mutations. By growing precursor lung cells from patients' own blood, they can screen for new drugs and validate responses in mature airway cells.
Researchers at the National University of Singapore have developed a treatment for vision loss through the transplantation of photoreceptor precursors. This innovative approach holds great promise as an alternative to gene therapy, which has limited efficacy due to genetic heterogeneity and advanced retinal degeneration.
A recent study published at Masonic Medical Research Institute found that electrocution-induced physiological stress can lead to overlapping cardiac conditions in individuals. The research used human induced pluripotent stem cells to investigate the mechanisms behind these conditions, shedding light on potential new treatments.
A new study created a model to show how dysfunction of air sac cells initiates fibrotic cascade in lung diseases like IPF and chILD. The study used patient-specific cells with altered genes to test novel therapeutics, offering hope for developing effective treatments without risky biopsies.
Using human stem cells and small molecules, researchers successfully differentiated them into insulin-producing pancreatic beta cells. This breakthrough could lead to a personalized treatment option for type 1 diabetes, reducing costs and increasing accessibility for those affected.
Researchers at Masonic Medical Research Institute are using human induced pluripotent stem cells (hiPSCs) to create scientific models for studying cardiac arrhythmias and testing therapeutics. The integration of mathematical modeling tools enables the prediction of drug efficacy with minimal adverse effects.
Researchers at UCLA developed brain organoids that mimic human brain structure and function, allowing for the study of neurological disorders like Rett syndrome. The organoids showed organized waves of activity similar to those found in living brains and responded to treatment with an experimental drug.
A study published in Science Translational Medicine identified a common cellular defect in ALS that can be treated with an antisense oligonucleotide drug. Researchers found that the accumulation of CHMP7 protein in the nucleus leads to nuclear pore injury and TDP-43 mislocalization, ultimately causing cell death.
The June edition of SLAS Technology features protocols for controlled cell seeding, splitting and expansion of human fibroblasts, induced pluripotent stem cells, and neural progenitor cells. Researchers have made significant improvements in forming complex 3D structures but face challenges in automating assay protocols.
Researchers created human induced pluripotent stem cells-derived intestinal organoids to study SARS-CoV-2's effects on the gut. This new model enables testing of potential therapeutics and identifying common disease mechanisms that can be targeted by drugs.
Researchers from Osaka University successfully generated functional conjunctival tissue in a dish, enabling the study of conjunctivae and the development of novel drugs for dry eye disease. The newly formed tissue contained goblet cells that produce mucins, mimicking human conjunctival biology.
Researchers developed a stem cell-based cell culture model for nonalcoholic fatty liver disease (NAFLD), revealing key findings on gene expression, lipid droplet morphology, and metabolic networks. The model also showed promising results with AdipoRon, a synthetic analogue that positively influences hepatocyte metabolism.
Researchers at the University of New South Wales have created adaptive stem cells, called induced multipotent stem cells (iMS), from human fat. These cells can reprogram to act as stem cells and adapt to their surroundings, repairing a range of damaged tissues in mice.
Scientists successfully created airway basal stem cells in vitro from induced pluripotent stem cells, which may lead to new treatments for airways and lungs damaged by various diseases. The study's findings could also enable the development of disease models and targeted drug approaches.
A study found that herpes simplex virus type 1 infection can cause impaired neuronal differentiation and abnormal brain structure in the human fetus, contributing to long-term neurological problems. The research also identified HSV-1-infected microglia promoting inflammation and suggesting new therapeutic avenues for targeting viral re...
Researchers found that exosomes secreted by cardiac cells derived from human induced pluripotent stem cells improved myocardial recovery and reduced arrhythmia in pigs. The treatment showed regenerative benefits equivalent to injecting living cells, without increasing the risk of tumorigenesis.
A novel, rapid carcinogen detection method using stem cells has been developed by scientists at Okayama University. The method, which takes only one week to yield results, involves testing chemicals on healthy stem cells to see if they convert into cancerous stem cells.
A study published in Cell Reports reveals that human acute myeloid leukemia (AML) stem cells are dependent on the transcription factor RUNX1, which could lead to lasting remissions or even cures. The researchers used induced pluripotent stem cells from a patient with AML to recreate leukemia stem cell biology in the lab.
Researchers successfully reversed diabetes in mice by using genetically edited stem cells derived from patients with a rare genetic form of insulin-dependent diabetes. The CRISPR-Cas9 gene-editing tool corrected a genetic defect that caused the disease, allowing the human stem cells to normalize blood sugar levels.
Scientists at Osaka University have developed a new method to isolate and generate human corneal tissue from induced pluripotent stem cells. By using specific proteins and magnetic-activated cell sorting technology, researchers were able to purify corneal epithelial cells and produce highly pure corneal sheets for therapeutic purposes.
Scientists from Osaka University created a new cellular model of the human eye using hiPSCs, enabling them to isolate specific cells involved in eye development and study related diseases. The novel model uses PITX2, a key protein during eye development, to track cell expression and differentiate between eye cells.
Boston researchers developed a novel approach to generate intestinal organoids in vitro using human induced pluripotent stem cells. The protocol allows for the creation of three-dimensional groups of intestinal cells, enabling disease treatment testing and uncovering novel therapies.
Scientists at Okayama University created a human stem cell-based model of myocardial infarction, allowing for the evaluation of tissue damage and inflammation. This new model offers a more accurate representation of human heart conditions, enabling the development of more effective preventive and therapeutic medicines.
A new bioinformatics tool, MHcut, reveals that microhomology-mediated end joining is more common in humans than previously thought. Using this tool and commercial genome-editing technology, researchers created precise gene mutations to model diseases, providing insights into rare and orphan diseases.
Scientists successfully induce pluripotency in adult cat cells, generating stem cells that can differentiate into various cell types. The breakthrough may lead to the development of cellular models for genetic diseases affecting domestic cats and similar human disorders.
A new study found that schizophrenia's neurobiological mechanisms vary between males and females, with many genes related to the illness expressed differently in each. This suggests that sex-specific treatments may be necessary to address the different underlying causes of schizophrenia in males and females.
Researchers at University of Wisconsin-Madison find pIC accelerates cellular maturation, leading to more mature and functional cardiac muscle cells. The compound activates epigenetic changes, including increased expression of the JAG1 gene, resulting in improved contractility and electrical efficiency.
Researchers find that human iPSCs can efficiently produce highly purified extracellular vesicles for treating aging-related diseases. These vesicles contain proteins and other treatments that can help repair damaged cells, and may one day be used to treat progeria and ALS.
Researchers at Helmholtz Munich discover key molecules in the cell nucleus that orchestrate paraspeckles formation, a structure linked to ALS progression. The discovery provides new insights into pluripotency and differentiation processes, potentially leading to breakthroughs in regenerative medicine and therapeutic strategies for ALS.
Researchers used time-lapse imaging to show that mouse induced pluripotent stem cells differentiated into cardiomyocytes significantly faster at microgravity. The study, published in Stem Cells and Development, suggests a promising area of research for regenerative medicine and manned space travel.
Researchers at Mayo Clinic have created a more efficient method for reprogramming induced pluripotent stem cells, reducing the process from four factors to one. The new system combines genetic cocktails into a single measles virus vector, making it faster and safer for clinical translation.
A study from Osaka University reveals how human pluripotent stem cells can be differentiated into corneal and retinal cells by growing them on specific forms of the protein laminin. The findings show that different laminin isoforms affect cell behavior, density, and interactions, which in turn influence the types of ocular cells produced.